XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/newsfda-accepts-to-review-ipsens-sbla-for-dysport-to-treat-upper-limb-spasticity-in-adults-4455267/20%Daily2014-11-30 18:30
https://www.clinicaltrialsarena.com/news/newsdynavax-regains-full-rights-to-dv1179-after-expiration-of-deal-with-gsk-4455682/20%Daily2014-11-30 18:30
https://www.clinicaltrialsarena.com/news/newsvancouver-offers-prescription-heroin-to-addicts-outside-of-clinical-trial-4454056/20%Daily2014-11-27 18:30
https://www.clinicaltrialsarena.com/news/newsablynx-reports-positive-phase-i-trial-results-of-caplacizumab-to-treat-ttp-4454302/20%Daily2014-11-27 18:30
https://www.clinicaltrialsarena.com/news/newsgsk-and-nihs-ebola-vaccine-shows-promise-in-first-phase-i-human-trial-4452678/20%Daily2014-11-26 18:30
https://www.clinicaltrialsarena.com/news/newssynthon-begins-dosing-in-phase-i-trial-of-syd985-to-treat-metastatic-solid-tumours-4453106/20%Daily2014-11-26 18:30
https://www.clinicaltrialsarena.com/news/newsamgen-and-astrazeneca-report-positive-results-from-phase-iii-trial-of-brodalumab-4451086/20%Daily2014-11-25 18:30
https://www.clinicaltrialsarena.com/news/newsbms-five-prime-to-study-nivolumab-and-fpa008-combination-in-six-tumour-types-4451319/20%Daily2014-11-25 18:30
https://www.clinicaltrialsarena.com/news/newsjanssen-to-start-phase-ii-trial-of-daratumumab-in-smoldering-multiple-myeloma-in-2015-4449748/20%Daily2014-11-24 18:30
https://www.clinicaltrialsarena.com/news/newsintra-cellular-reports-additional-results-from-phase-iii-trial-of-iti-007-4449983/20%Daily2014-11-24 18:30
https://www.clinicaltrialsarena.com/news/newsxenetic-completes-dosing-in-phase-ii-trial-of-myeloxen-to-treat-multiple-sclerosis-4448650/20%Daily2014-11-23 18:30
https://www.clinicaltrialsarena.com/news/newsneurotrope-completes-dosing-in-bryostatin-1-phase-iia-trial-for-alzheimers-disease-4448670/20%Daily2014-11-23 18:30
https://www.clinicaltrialsarena.com/marketdata/featureten-blockbuster-drugs-that-lost-patent-in-2014-4445799/20%Daily2014-11-20 18:30
https://www.clinicaltrialsarena.com/news/newscharleston-and-daiichi-sankyo-begin-two-phase-iii-trials-of-cl-108-4447005/20%Daily2014-11-20 18:30
https://www.clinicaltrialsarena.com/news/newsotologic-begins-phase-i-trial-of-hnpn-1010-to-treat-hearing-disorders-4447170/20%Daily2014-11-20 18:30
https://www.clinicaltrialsarena.com/news/newsimmunovaccine-to-begin-phase-ii-trial-of-lymphoma-vaccine-dpx-survivac-4445593/20%Daily2014-11-19 18:30
https://www.clinicaltrialsarena.com/news/newsgalena-completes-patient-enrolment-in-phase-ii-gale-401-trial-4445732/20%Daily2014-11-19 18:30
https://www.clinicaltrialsarena.com/news/newssarepta-starts-dosing-in-eteplirsen-trial-to-treat-ambulant-patients-with-dmd-4444087/20%Daily2014-11-18 18:30
https://www.clinicaltrialsarena.com/news/newsnovavax-enrols-first-patient-in-phase-ii-trial-of-quadrivalent-seasonal-influenza-vlp-4444448/20%Daily2014-11-18 18:30
https://www.clinicaltrialsarena.com/news/newsfive-prime-starts-dosing-patients-in-fpa008-phase-i-trial-to-treat-rheumatoid-arthritis-4442472/20%Daily2014-11-17 18:30
https://www.clinicaltrialsarena.com/news/newsbristol-myers-squibbs-phase-iii-trial-of-opdivo-meets-primary-end-point-4442749/20%Daily2014-11-17 18:30
https://www.clinicaltrialsarena.com/news/newsmercks-phase-ii-trial-of-melanoma-drug-pembrolizumab-meets-primary-endpoint-4441081/20%Daily2014-11-16 18:30
https://www.clinicaltrialsarena.com/news/newsbayer-starts-phase-ii-trial-of-riociguat-to-treat-patients-with-dcssc-4441423/20%Daily2014-11-16 18:30
https://www.clinicaltrialsarena.com/news/newsgenkyotex-closes-patient-enrolment-in-gkt137831-phase-ii-trial-for-diabetic-nephropathy-4439271/20%Daily2014-11-13 18:30
https://www.clinicaltrialsarena.com/news/newsmatinas-biopharma-starts-dosing-in-human-trial-of-mat9001-4439610/20%Daily2014-11-13 18:30
https://www.clinicaltrialsarena.com/news/newssarepta-doses-first-patient-in-eteplirsen-trial-to-treat-duchenne-muscular-dystrophy-4437969/20%Daily2014-11-12 18:30
https://www.clinicaltrialsarena.com/news/newsastrazeneca-and-amgens-brodalumab-meets-endpoints-in-plaque-psoriasis-trial-4438068/20%Daily2014-11-12 18:30
https://www.clinicaltrialsarena.com/news/newssanofi-and-regeneron-report-positive-phase-iib-trial-results-of-dupilumab-in-asthma-patients-4435831/20%Daily2014-11-11 18:30
https://www.clinicaltrialsarena.com/news/newsoncothyreon-celldex-begin-phase-ib-combination-trial-of-ont-10-and-varlilumab-4436383/20%Daily2014-11-11 18:30
https://www.clinicaltrialsarena.com/news/newsuniversity-of-nebraska-medical-center-evaluating-new-alzheimers-drug-4434756/20%Daily2014-11-10 18:30
https://www.clinicaltrialsarena.com/news/newsboehringers-phase-iii-lux-lung-3-trial-of-afatinib-meets-primary-endpoint-4434867/20%Daily2014-11-10 18:30
https://www.clinicaltrialsarena.com/news/newscardiome-reports-positive-phase-iii-a-p-trial-results-of-brinavess-in-af-patients-4433147/20%Daily2014-11-09 18:30
https://www.clinicaltrialsarena.com/news/newsexelixis-completes-enrolment-in-phase-iii-meteor-trial-of-carcinoma-drug-cabozantinib-4433299/20%Daily2014-11-09 18:30
https://www.clinicaltrialsarena.com/news/newsmerrimack-begins-phase-i-trial-of-mm-398-to-treat-brain-cancer-4431483/20%Daily2014-11-06 18:30
https://www.clinicaltrialsarena.com/news/newsalnylam-closes-phase-ii-enrolment-and-begins-revusiran-ole-trial-4431694/20%Daily2014-11-06 18:30
https://www.clinicaltrialsarena.com/news/newscelsion-gets-vhp-approval-to-begin-phase-iii-optima-liver-cancer-trial-of-thermodox-4430178/20%Daily2014-11-05 18:30
https://www.clinicaltrialsarena.com/news/newsxoma-initiates-phase-iii-gevokizumab-trial-to-treat-active-ulcers-in-patients-with-pg-4430279/20%Daily2014-11-05 18:30
https://www.clinicaltrialsarena.com/news/newsironwood-begins-phase-iii-trial-of-linaclotide-72mcg-in-adults-with-chronic-idiopathic-constipation-4428404/20%Daily2014-11-04 18:30
https://www.clinicaltrialsarena.com/news/newskolltan-initiates-ktn3379-phase-ib-cancer-trial-in-combination-with-targeted-therapies-4428733/20%Daily2014-11-04 18:30
https://www.clinicaltrialsarena.com/news/newsanavex-gets-australian-ethics-committee-approval-to-begin-phase-iia-alzheimers-disease-trial-4426828/20%Daily2014-11-03 18:30
https://www.clinicaltrialsarena.com/news/newsxcovery-reports-positive-phase-i-results-of-x-396-in-alk-positive-nsclc-4426992/20%Daily2014-11-03 18:30
https://www.clinicaltrialsarena.com/marketdata/featurefirst-ebola-trial-novartis-4428184/20%Daily2014-11-03 18:30
https://www.clinicaltrialsarena.com/news/newsanamars-amap102-fails-to-meet-primary-endpoint-in-exploratory-phase-iia-trial-4425357/20%Daily2014-11-02 18:30
https://www.clinicaltrialsarena.com/news/newsmedivation-and-astellas-to-begin-phase-iii-trial-of-enzalutamide-to-treat-prostate-cancer-4425621/20%Daily2014-11-02 18:30